Integrin beta3
-
Subject Areas on Research
- Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors.
- Captopril-enhanced binding of PlA1 (HPA-1a) antibodies in posttransfusion purpura.
- Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression.
- Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells.
- Effects of variations in serum estradiol concentrations on secretory endometrial development and function in experimentally induced cycles in normal women.
- Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women.
- Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes.
- Integrin-mediated interactions with extracellular matrix proteins for nucleus pulposus cells of the human intervertebral disc.
- Isoprenylcysteine carboxylmethyltransferase function is essential for RAB4A-mediated integrin β3 recycling, cell migration and cancer metastasis.
- Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
- Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch.
- Platelet PlA2 polymorphism and platelet activation are associated with increased troponin I release after cardiopulmonary bypass.
- Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
- Platelet reactivity and thrombogenicity in postmenopausal women.
- Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase.
- Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ανβ3 testing in women with unexplained infertility.
- Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers.
- The endometria of women with endometriosis exhibit dysfunctional expression of complement regulatory proteins during the mid secretory phase.
- Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions.
- Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo.
- What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention?